OFG
GILD icon

OmniStar Financial Group’s Gilead Sciences GILD Stock Holding History

OmniStar Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,697
Closed -$805K – 132
2021
Q2 		$805K Buy
+11,697
New +$781K 1% 37

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OmniStar Financial Group's GILD Position: Q2 2026 in Review

OmniStar Financial Group increased its Gilead Sciences (GILD) stake by 5.4% in Q2 2026, buying an estimated $175K and bringing the position to 25,644 shares worth $3.24M. The position accounts for 1.49% of the portfolio, ranked #18.

OmniStar Financial Group first reported a position in GILD in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.16M in Q4 2025. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • OmniStar Financial Group held 25,644 shares of Gilead Sciences worth $3.24M as of Q2 2026.
  • OmniStar Financial Group bought 1,325 Gilead Sciences shares in Q2 2026, an estimated $175K.
  • Gilead Sciences made up 1.49% of OmniStar Financial Group's portfolio in Q2 2026, its #18 holding.
  • OmniStar Financial Group first reported a position in Gilead Sciences in Q4 2017 and has held it in 34 quarters since.
  • OmniStar Financial Group's Gilead Sciences position peaked at $4.16M in Q4 2025.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on OmniStar Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.